Clinical Trials Directory

Trials / Completed

CompletedNCT03129386

Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is investigating the normal range of maximal diaphragm thickness during a sniff inspiratory manoeuvre using ultrasound in healthy subjects stratified by age and gender.

Detailed description

Diaphragm dysfunction is associated with poor clinical outcomes in critically ill patients but is difficult to diagnose. Traditionally, diaphragm function is measured by evaluating inspiratory muscle strength via maximal inspiratory pressure (MIP). However, this technique relies on a volitional maximal effort and can be challenging for patients to perform. An alternative to measuring inspiratory muscle strength is the sniff inspiratory pressure approach. During short, sharp sniffs, the diaphragm is maximally activated. Currently, there are no reported values of the normal range of maximal diaphragm thickness during a sniff maneuver. This study will define the normal range of values for sniff maximal diaphragm thickening fraction, maximal thickening against an occluded airway, and diaphragm thickening during resting tidal breathing in healthy subjects.

Conditions

Timeline

Start date
2016-06-08
Primary completion
2018-12-01
Completion
2019-01-01
First posted
2017-04-26
Last updated
2019-04-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03129386. Inclusion in this directory is not an endorsement.

Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction (NCT03129386) · Clinical Trials Directory